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Ultraviolet light A (UVA) exposure is thought to cause skin aging mainly by singlet oxygen (1O2)-dependent pathways.
Using microarrays, we assessed whether pre-treatment with the 1O2 quencher b-carotene (bC; 1.5 lM) prevents UVA-
induced gene regulation in HaCaT human keratinocytes. Downregulation of growth factor signaling, moderate in-
duction of proinﬂammatory genes, upregulation of immediate early genes including apoptotic regulators and sup-
pression of cell cycle genes were hallmarks of the UVA effect. Of the 568 UVA-regulated genes, bC reduced the UVA
effect for 143, enhanced it for 180, and did not interact with UVA for 245 genes. The different interaction modes imply
that bC/UVA interaction involved multiple mechanisms. In unirradiated keratinocytes, gene regulations suggest that
bC reduced stress signals and extracellular matrix (ECM) degradation, and promoted keratinocyte differentiation. In
irradiated cells, expression proﬁles indicate that bC inhibited UVA-induced ECM degradation, and enhanced UVA
induction of tanning-associated protease-activated receptor 2. Combination of bC-promoted keratinocyte differen-
tiation with the cellular ‘‘UV response’’ caused synergistic induction of cell cycle arrest and apoptosis. In conclusion,
bC at physiological concentrations interacted with UVA effects in keratinocytes by mechanisms that included, but
were not restricted to 1O2 quenching. The retinoid effect of bC was minor, indicating that the bC effects reported here
were predominantly mediated through vitamin A-independent pathways.
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Ultraviolet light A (UVA) exposure is thought to cause skin
aging mainly by singlet oxygen (1O2)-dependent pathways.
1O2 mediates gene regulation via the transcription factor AP-2
(Grether-Beck et al, 1996). Furthermore, like UVB/UVA2, UVA1
activates stress-activated protein kinases (Kick et al, 1996).
b-carotene (bC) has the potential to protect skin firstly,
because it is an excellent 1O2 quencher (Cantrell et al,
2003). During UVA exposure, skin is regularly exposed to
1O2, and is thus a most relevant tissue to test
1O2 quenching
by bC in living cells. Secondly, bC scavenges reactive ox-
ygen species (ROS) other than 1O2 (Krinsky and Yeum,
2003). Thirdly, bC mildly reduces sunburn (Mathews-Roth
et al, 1972; Stahl et al, 2000). Furthermore, bC can be me-
tabolized to retinoic acid (RA), a signaling molecule involved
in skin maintenance.
To analyze the efficacy of bC in skin protection, HaCaT
human keratinocytes were pre-treated for 2 d with bC at 1.5
mM, a typical concentration in human plasma after moder-
ate dietary supplementation (Thurmann et al, 2002). Sub-
sequently, the cells were irradiated with SSR consisting of
UVA1/2 as major light spectrum—further referred to as UVA.
Using transcriptomics, we analyzed how bC influences the
response of HaCaT cells to UVA exposure. Moreover, we
analyzed the effect of bC in unirradiated cells.
Results and Discussion
Cellular uptake of bC from the culture medium was con-
firmed by HPLC analysis. Cells contained 20.06  5.66
pmol bC per 106 cells after incubation with medium con-
taining 1.85  0.09 mM bC. During the 24 h of incubation,
the bC concentration dropped to approximately 50% (not
shown), irrespective of the presence of cells. No bC was
detected in placebo controls.
One thousand four hundred and fifty eight genes were
significantly regulated by at least one of the treatments. bC
regulated 381 and UVA influenced 568 genes. One thou-
sand one hundred and forty two genes were regulated in
UVA/bC-treated cells, 610 of which were not regulated by
the single treatments.
bC effects in unirradiated keratinocytes (Table S1; Fig 1a)
bC reduced stress responses Stress stimuli, like UV irradia-
tion or oxidative stress, e.g., resulting from ROS production
in the respiratory chain, elicit a cellular stress response,
Abbreviations: bC, b-carotene; ECM, extracellular matrix; IL, in-
terleukin; JNK, c-Jun N-terminal kinase; MMP, matrix metallopro-
teases; 1O2, singlet oxygen; QRT-PCR, quantitative real-time RT-
PCR; RA, retinoic acid; ROS, reactive oxygen species; SAPK,
stress-activated protein kinase; UVA, ultraviolet light A; VEGF, vas-
cular endothelial growth factor
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leading to the induction of immediate early genes. bC down-
regulated several immediate early genes (GEM, KRS-2, JUN-
B, FRA-2, EGRa), and oxidative stress defense genes (NCF2,
NRF2b1). This suggests that bC reduced cellular stress in-
cluding oxidative stress in unirradiated keratinocytes.
bC reduced basal matrix metalloproteases (MMP)-10 ex-
pression Degradation of extracellular matrix (ECM) mole-
cules by MMP in skin are a key process in skin aging. bC
reduced the basal expression of MMP-10. We recently
confirmed this by quantitative real-time RT-PCR (QRT-PCR)
in independent experiments (Wertz et al, 2004). MMP-10
cleaves various ECM molecules, but also activates other
MMP. Because of its broad substrate specificity, MMP-10 is
likely involved in MMP-mediated skin aging.
Together with our findings that bC mildly reduces basal
MMP-1 expression (Wertz et al, 2004), this argues that bC
reduces ECM degradation in unirradiated skin, and can
therefore delay skin aging.
bC promoted normal keratinocyte differentiation The re-
sponse of HaCaT cells to bC treatment was consistent with
the cells undergoing differentiation. Firstly, bC downregu-
lated genes associated with growth factor signaling (e.g.,
EGFR, NOTCH3, BMP2a, Wnt5a) and cell cycle regulation
(e.g., ID-2, DNA ligase III, BUB1). Secondly, bC regulated
marker genes for physiological keratinocyte differentiation:
keratin 15 was decreased, whereas the basement mem-
brane collagen COL4A5, and the hemidesmosomal cell ad-
hesion molecules BPAG1 and integrin a6 were decreased.
QRT-PCR confirmed downregulation of integrin a6 (Fig 2a).
Since keratinocyte differentiation involves apoptosis, it is
interesting that bC upregulated several proapoptotic genes
(Bax, endogl–2, requiem). This was in part counterbalanced
by downregulation of immediate early genes, some of which
favor apoptosis (e.g., TSSC3/IPL, EGRa). We conclude that
bC prepared cells for apoptosis, but was not sufficient to
induce apoptosis, as confirmed in a functional apoptosis
assay (Fig 3; unirradiated cells). This argues that bC pro-
moted differentiation, but did not induce late terminal dif-
ferentiation steps in keratinocytes.
bC differentially regulated immune modulators bC report-
edly stimulates immune function (Hughes, 2001). bC up-
regulated TLR3, a receptor involved in innate immunity, and
interleukin (IL)-6, an important regulator of inflammation,
keratinocyte growth, and wound healing. bC mildly down-
regulated vascular endothelial growth factor (VEGF), a key
angiogenic factor, and COX-2, the rate-limiting enzyme
in prostaglandin synthesis. Moreover, bC downregulated
Figure1
Model of molecular events, as deduced from the array data. (a)
b-carotene (bC) effects in unirradiated keratinocytes; (b) ultraviolet
light A (UVA) effects in keratinocytes; (c) bC effects in UVA-irradiated
keratinocytes. Genes labeled red were upregulated, genes labeled
green were downregulated by the treatment. bC quenched the UVA
effect for genes labeled blue.
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IL-18, an IL-12-related growth and differentiation factor for
Th1 cells. Overall, bC differentially regulated inflammatory
signals in unirradiated keratinocytes.
bC acted predominantly via RA-independent path-
ways Among presumed RA-regulated genes, only retinol
short chain dehydrogenase 1 (retSDR1) was induced by bC.
Other known RA targets (Balmer and Blomhoff, 2002) were
either not altered by bC, or were downregulated (e.g., HOX-
D4), indicating that the effects of bC described here were
mainly RA independent.
bC effects in UVA-irradiated keratinocytes (Table SI;
Fig 1c)
bC interacts with UVA by multiple mechanisms UVA elicited
downregulation of growth factor-dependent signaling cas-
cades, moderate induction of proinflammatory genes, in-
duction of immediate early genes including apoptotic
regulators, and suppression of cell cycle genes (Fig 1b).
He et al (2004) made very similar observations in UVA-irra-
diated HaCaT cells. Of the 568 UVA-regulated genes, bC
quenched the UVA effect on 143 genes, i.e., they had ex-
pression profiles expected for 1O2-induced genes. On the
other hand, bC enhanced the UVA effect for 180 genes, and
had no influence on UVA regulation of 245 genes. These
different modes of interference imply several mechanisms
of UVA/bC interaction.
bC inhibited expression of MMP-10 and promoted expres-
sion of protease inhibitors Chronic sun exposure causes
degradation of ECM proteins by inducing MMP in skin,
leading to premature skin aging. In our experiments, UVA
irradiation induced MMP-10. bC inhibited MMP-10 expres-
sion in UVA-irradiated keratinocytes. We recently showed
that MMP-10 induction involves 1O2, and confirmed that bC
concentration dependently inhibited MMP-10 induction by
UVA/D2O. Hence, bC acts as a
1O2 quencher in living cells.
bC also reduced the basal and 1O2-induced expression of
MMP-1, and downregulated UVA induction of MMP-3
(Wertz et al, 2004). Furthermore, bC upregulated the
protease inhibitors Lekti and serpinB1. TIMP-1, a likely
MMP-10 inhibitor, was not influenced by the treatments.
Overall, the data argues that bC diminished UVA-induced
ECM degradation, indicating that bC at physiological con-
centrations may delay photoaging. Battistutta et al (2000)
provided preliminary clinical evidence that bC supplemen-
tation may indeed reduce wrinkling.
Figure 2
b-carotene downregulated (a) integrin a6 expression in irradiated
and unirradiated HaCaT cells. bC enhanced ultraviolet light A
(UVA)-induced (b) GADD34 and (c) GADD153 expression. Cells were
supplemented with bC for 2 d and prior to UVA irradiation (270 kJ per
m2) either in normal phosphate-buffered saline (PBS) or D2O-PBS.
Gene expression 5 h after irradiation was determined by quantitative
real-time RT-PCR. Values are geometric mean  standard error of three
experiments.
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Figure3
b-carotene (bC) concentration dependently induced caspase-3 ac-
tivity in ultraviolet light A (UVA)-irradiated keratinocytes. Cells were
supplemented with bC for 2 d and prior to UVA irradiation (270 kJ per
m2). Caspase-3 activity was determined at 5 h after irradiation. Values
are mean  standard error of an experiment with four replicates.
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bC differentially regulated proinﬂammatory genes The cel-
lular UV response includes induction of proinflammatory
cytokines, but also immune suppression. bC prevents UV-
induced immune suppression (Fuller et al, 1992), and alle-
viates erythema after sun exposure (Gollnick et al, 1996;
Stahl et al, 2000).
UVA induced mild signs of inflammation. bC reduced
UVA upregulation of VEGF and IFNa/b targets. VEGF in-
duction by UVA relies on an AP-2 site in the VEGF promoter
(Gille et al, 2000), suggesting a 1O2-dependent regulation.
VEGF downregulation may explain, how bC reduces ery-
thema formation after sun exposure. IL-6 expression was
weakly upregulated by UVA and enhanced by bC. IL-6 is
induced by IL-1 via a 1O2-dependent positive autoregula-
tory loop (Wlaschek et al, 1994). IL-6 can also be induced by
stress-activated protein kinase (SAPK)/c-Jun N-terminal
kinase (JNK) signaling (Kick et al, 1996). As bC did not
quench the UVA induction of JNK/SAPK target genes, we
propose that increased IL-6 induction by UVA and bC oc-
curred through JNK/SAPK signaling instead of the 1O2-de-
pendent loop. IL-6 induction is expected to counteract the
bC-mediated VEGF reduction, thus impeding a stronger
protection against erythema by bC.
bC enhanced UVA induction of protease-activated receptor 2
(PAR-2), a receptor required for tanning PAR-2 was expect-
edly induced by UVA and further increased by bC. Tronnier
(1984) reported that carotenodermia positively influences
pigmentation disorders independent of tanning. Raab et al
(1985), and Postaire et al (1997), however, found an increased
melanin contents in skin after supplementation with bC-
containing antioxidant mixtures. The result that bC en-
hanced UVA induction of PAR-2 can explain how carotenoid
supplementation enhances tanning after sun exposure.
bC acted predominantly via RA-independent pathways UVA
depletes cellular retinol stores (Sorg et al, 2002), possibly
leading to reduced RA availability. Accordingly, RA target
genes (Balmer and Blomhoff, 2002) were downregulated by
UVA irradiation. Except for retSDR1, bC did not restore
expression of RA target genes. We recently observed that
HaCaT cells produce low amounts of retinoid activity from
bC (Wertz et al, 2004), rendering HaCaT cells an excellent
model to evaluate provitamin A-independent functions of bC.
bC further promoted differentiation in irradiated keratino-
cytes Expression of differentiation markers indicate that
bC promoted keratinocyte differentiation even stronger in
UVA-irradiated cells than in unirradiated cells. UVA/bC
treatment downregulated more genes encoding basement
membrane collagens than the single treatments. Downreg-
ulation of BPAG1, integrin a6, ILK, desmocollins, and Cx45,
as well as upregulation of Cx31, KLF4, and GADD153
also indicate keratinocyte differentiation. This effect may
render combined bC/UVA treatment a promising therapy
for skin disorders associated with disturbed differentiation,
e.g., psoriasis.
bC did not prevent UVA-induced stress signals Activation of
JNK/SAPK, NF-kB, and induction of their target genes are
hallmarks of the cellular UV response. We found a massive
transcriptional counter-regulation of these signaling path-
ways upon UVA irradiation. Expression profiles of protein
kinases and phosphatases, and upregulation of target
genes (C-FOS, FRA-1, JUND, ATF4, MAF-F, DKK-1, GEM)
are consistent with a stress response induced by SAPK/
JNK activation. bC did not inhibit these UVA effects, and
enhanced some.
Few genes associated with oxidative stress were regu-
lated. UVA induced, e.g., OSR-1/STK25, a ROS-activated
kinase, and thioredoxin (Trx) reductase, which together with
Trx acts at the core of antioxidant defense. bC favored
these protective gene regulations.
The data overall suggest that stress signaling was acti-
vated by UVA. bC did not inhibit these UVA effects, and
enhanced some.
‘‘UV response’’ of keratinocytes undergoing bC-induced
differentiation led to cell cycle arrest and apoptosis
SAPK/JNK signaling often leads to cell cycle arrest and
apoptosis. Expression profiles of cell cycle regulators ar-
gues that cell cycle arrest was induced by UVA and further
enhanced by bC.
UVA induced several genes that function during the G1
cell cycle phase (cyclin E, p57KIP2, ornithine decarboxylase).
The vast majority of cell cycle regulators functioning in later
cell cycle phases was downregulated by UVA, indicating
cell cycle arrest at the late G1 phase. Examples comprise
the proliferation marker Ki67, genes involved in DNA rep-
lication or encoding mitotic spindle proteins. Moreover, UVA
downregulated several growth factor receptors and mem-
bers of the downstream signaling machinery. bC alone also
downregulated genes involved in growth factor signaling,
and reduced expression of cell cycle regulators in the con-
text of its differentiation-promoting activity. The combined
UVA/bC treatment led to a more pronounced cell cycle ar-
rest than the single treatments.
Table I. Primers and probes used for QRT-PCR
Transcript Forward primer Reverse primer Probe
Integrin a6 TTTCCCGTTTCTTTCTTGAGTTGT TGGAAAAGGTAACTTGTGAGCCA AGACTCCGTTAGGTTCAGGGAGTT-
TATCTCCTTTT
GADD34 CGGACCCTGAGACTCCCC AAGGCCAGAAAGGTGCGCTTCTC GAAATGGACAGTGACCTTCTCG
GADD153 GCAAGAGGTCCTGTCTTCAGATG CACCTCCTGGAAATGAAGAGGAAGAATCA GGGTCAAGAGTGGTGAAGATTTTT
18S rRNA CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT TGCTGGCACCAGACTTGCCCTC
QRT-PCR, quantitative real-time RT-PCR; UVA, ultraviolet light A; MMP, matrix metalloproteases.
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Following cell cycle arrest, cells can re-enter the cell cy-
cle or undergo apoptosis. Here, UVA irradiation induced
several apoptotic regulators, including the immediate early
genes IEX-1, GADD34, GADD153, ERF-2, and TSSC3/IPL.
bC enhanced UVA induction of GADD153, GADD34,
TDAG51, and ERF–2. The expression profiles of GADD153
and GADD34 were confirmed by QRT-PCR (Fig 2b, c). The
data are consistent with previous evidence that UVA causes
apoptosis subsequent to SAPK/JNK activation (see also He
et al, 2004). bC did not reduce this UVA effect. Some gene
regulations were enhanced by bC. Apoptosis induction was
confirmed by assessing caspase-3 activity. Neither UVA nor
bC alone activated caspase-3. bC cooperated with UVA to
induce caspase-3 activity in a concentration-dependent
manner (Fig 3).
Together, cells pre-treated with bC and irradiated with
UVA underwent G1 cell cycle arrest and apoptosis. If this
process takes place also in vivo, bC should favor sunburn
cell formation. Although a mild reduction in sunburn ery-
thema was found in several studies, bC supplementation
did not alter the number of sunburn cells in humans (Gar-
myn et al, 1995). Induction of apoptosis in the p53-deficient
HaCaT cells would imply a favorable removal of pre-can-
cerous cells, and bC supplementation in most cases indeed
reduced skin carcinogenesis in rodents (e.g., Mathews-
Roth, 1982). Clinical intervention trials, however, have found
no significant prevention of non-melanoma skin cancer
(Greenberg et al, 1990; Green et al, 1999) by bC. Besides
carotenoids, the skin contains other antioxidants, which are
expected to prevent bC from enhancing some of the UVA
effects in vivo. Furthermore, HaCaT cells are exceptionally
sensitive to UV-induced apoptosis (Chaturvedi et al, 2001).
Thus, even though the consequences in skin might be less
pronounced than in HaCaT cells, we argue that the mech-
anisms identified here nevertheless apply in vivo.
Proposed relationship of the modes of action of bC to its
inﬂuence on UVA-induced biological processes (Fig
4) We propose that bC reduced UVA induction of genes
involved in ECM degradation and inflammation as a 1O2
quencher. We suggest that the mild photoprotective effect
of bC is based on inhibition of these 1O2-induced gene
regulations, rather than on a physical filter effect. A physical
filter effect would be expected to reduce all UVA responses
by the same amount. bC, if scavenging ROS other than 1O2,
is irreversibly damaged and converted into radicals, if not
rescued by other antioxidants (Edge et al, 2000). Thus,
bC did not inhibit UVA-induced stress signals, and en-
hanced some. UVA exposure suppressed several RA target
genes. Since HaCaT cells produce marginal amounts of re-
tinoid activity from bC, the provitamin A activity of bC did
not translate into restored expression of RA target genes in
this system.
Conclusion
bC at physiological concentrations interacted with UVA ef-
fects in keratinocytes by multiple mechanisms that includ-
ed, but were not restricted to 1O2 quenching.
In unirradiated keratinocytes, bC reduced expression of
immediate early genes, indicating reduced stress signals.
Moreover, gene regulations by bC suggest decreased ECM
degradation, and increased keratinocyte differentiation.
This effect on differentiation was unrelated to UVA expo-
sure, but synergized with UVA effects. In UVA-irradiated
cells, bC inhibited gene regulations by UVA, which promote
ECM degradation, arguing for a photoprotective effect of
bC. bC enhanced UVA-induced PAR-2 expression, sug-
gesting that bC enhances tanning after UVA exposure. The
combination of bC-induced differentiation with the cellular
Figure 4
Proposed relationship of the modes of
action of b-carotene to its influence on
ultraviolet light A-induced biological
processes.
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‘‘UV response’’ led to a synergistic induction of cell cycle
arrest and apoptosis by UVA and bC.
The retinoid effect of bC was minor, indicating that the bC
effects reported here were predominantly mediated through
vitamin A-independent pathways.
Our results explain and integrate many conflicting reports
on the efficacy of bC as a 1O2 quencher and as a general
antioxidant in living cells. The identified mechanisms, by
which bC acts on the skin have implications on skin pho-
toaging, as well as on relevant skin diseases, such as skin
cancer and psoriasis.
Materials and Methods
bC and UVA treatment of keratinocytes The cell culture exper-
iments were carried out as described (Wertz et al, 2004). Briefly, a
subclone of passage 65 HaCaT keratinocytes, selected for differ-
entiation capacity, was used at passages 16–23 after subcloning.
2  105 cells were seeded per 60 mm dish. Starting the following
day, the cells were supplemented with bC for 2 d. bC-containing
medium was prepared as follows: fresh all-E-bC (DSM Nutritional
Products, Kaiseraugst, Switzerland) stock solution in THF (con-
taining 0.025% BHT; Fluka Chemie AG, Buchs, Switzerland) was
diluted 1:2 with ethanol, and added to cell culture medium to a final
concentration of 1.5 mM bC. The solvent concentration in the me-
dium was 0.5% for all treatments. bC-containing medium was
prepared fresh for the daily medium changes. On day 3 of the
experiment, cells were irradiated with a Ho¨nle sun lamp Sol 500
(270 kJ per m2; Dr Ho¨nle, Planegg, Germany). The concentration of
bC in media and cells was assessed by HPLC.
Affymetrix GeneChips analysis Five independent, factorially de-
signed cell irradiation experiments were analyzed by microarray
hybridization. For each experiment, one chip was hybridized per
treatment condition. GeneChip (Affymetrix, Oxford, UK) analysis
was done as described (Siler et al, 2004). Gene regulations by bC
and/or UVA were calculated relative to placebo. Gene regulations
are reported as ‘‘change factors’’, defined as ‘‘(treatment/control)-
1’’ (in case of an increase), or ‘‘(control/treatment)þ 1’’ (in case of
a decrease), or zero (in case of no change). Changes in gene ex-
pression were only included in further analysis, if the change factor
wasX0.5 orp0.5, and if unpaired t tests yielded p valuesp0.05.
To identify pathways affected by the treatments, functional infor-
mation on the genes was retrieved from public literature databases.
QRT-PCR Key gene regulations were confirmed in three inde-
pendent cell irradiation experiments using TaqManTM QRT-PCR
(Applied Biosystems, Rotkreuz, Switzerland) as described (Wertz
et al, 2004). The sequences of the primers and probes used are
given in Table 1. In these experiments, cells were pre-treated with
0.5, 1.5, or 3 mM bC, to analyze for concentration-dependent bC
effects. Moreover, cells were irradiated either in D2O-containing
phosphate-buffered saline (PBS) or in H2O-containing PBS, to
analyze for the 1O2 inducibility of genes.
Apoptosis assay Caspase-3 activity 5 h after UVA irradiation was
quantified in five separate experiments using the CaspACE Assay
System (Promega/Catalys, Wallisellen, Switzerland).
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